Anca Reschner

1.4k total citations
27 papers, 1.1k citations indexed

About

Anca Reschner is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Anca Reschner has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 7 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Anca Reschner's work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (6 papers). Anca Reschner is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (6 papers). Anca Reschner collaborates with scholars based in Belgium, Switzerland and United States. Anca Reschner's co-authors include Giulio C. Spagnoli, Iván Martín, Sourabh Ghosh, Michael Heberer, Philippe Demougin, Chantal Feder‐Mengus, Alain Vanderplasschen, Jacques Boniver, Elisabetta Padovan and Daniel Oertli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Annals of Surgery.

In The Last Decade

Anca Reschner

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anca Reschner Belgium	17	484	382	313	274	155	27	1.1k
John F. Whitesides United States	16	733 1.5×	364 1.0×	309 1.0×	124 0.5×	135 0.9×	35	1.5k
Leyuan Ma United States	15	584 1.2×	516 1.4×	566 1.8×	267 1.0×	184 1.2×	30	1.5k
Edwin R. Manuel United States	20	480 1.0×	468 1.2×	466 1.5×	343 1.3×	85 0.5×	39	1.3k
Ángel Cid-Arregui Germany	20	400 0.8×	432 1.1×	427 1.4×	87 0.3×	227 1.5×	44	1.1k
Julien Burlaud‐Gaillard France	21	293 0.6×	148 0.4×	578 1.8×	105 0.4×	346 2.2×	66	1.9k
Caitlin D. Lemke United States	15	474 1.0×	176 0.5×	344 1.1×	93 0.3×	54 0.3×	30	894
Andrew W. Woodham United States	15	337 0.7×	166 0.4×	389 1.2×	72 0.3×	301 1.9×	30	1.2k
Jennifer S. Sims United States	15	420 0.9×	176 0.5×	480 1.5×	84 0.3×	238 1.5×	21	1.2k
Douglas Hanlon United States	20	894 1.8×	318 0.8×	598 1.9×	177 0.6×	214 1.4×	38	1.6k
Ailin Bai United States	12	583 1.2×	254 0.7×	660 2.1×	44 0.2×	113 0.7×	19	1.2k

Countries citing papers authored by Anca Reschner

Since Specialization

Citations

This map shows the geographic impact of Anca Reschner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anca Reschner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anca Reschner more than expected).

Fields of papers citing papers by Anca Reschner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anca Reschner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anca Reschner. The network helps show where Anca Reschner may publish in the future.

Co-authorship network of co-authors of Anca Reschner

This figure shows the co-authorship network connecting the top 25 collaborators of Anca Reschner. A scholar is included among the top collaborators of Anca Reschner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anca Reschner. Anca Reschner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reschner, Anca, Coca Necsoi, Carole Nagant, et al.. (2021). Tetanus seroprotection in people living with HIV: Risk factors for seronegativity, evaluation of medical history and a rapid dipstick test. Vaccine. 39(14). 1963–1967. 2 indexed citations

Vandermeulen, Gaëlle, Kévin Vanvarenberg, Ans De Beuckelaer, et al.. (2015). The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation. Vaccine. 33(28). 3179–3185. 18 indexed citations

Boutier, Maxime, Maygane Ronsmans, Ping Ouyang, et al.. (2015). Rational Development of an Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine Using Prokaryotic Mutagenesis and In Vivo Bioluminescent Imaging. PLoS Pathogens. 11(2). e1004690–e1004690. 40 indexed citations

Rakus, Krzysztof, Ping Ouyang, Maxime Boutier, et al.. (2013). Cyprinid herpesvirus 3: an interesting virus for applied and fundamental research. Veterinary Research. 44(1). 85–85. 74 indexed citations

Reschner, Anca, Gaëlle Vandermeulen, Marc Daukandt, et al.. (2013). Use of Staby^®technology for development and production of DNA vaccines free of antibiotic resistance gene. Human Vaccines & Immunotherapeutics. 9(10). 2203–2210. 6 indexed citations

Vrancken, Robert, Maxime Boutier, Maygane Ronsmans, et al.. (2013). Laboratory validation of a lateral flow device for the detection of CyHV-3 antigens in gill swabs. Journal of Virological Methods. 193(2). 679–682. 13 indexed citations

Ouyang, Ping, Krzysztof Rakus, Maxime Boutier, et al.. (2013). The IL-10 homologue encoded by cyprinid herpesvirus 3 is essential neither for viral replication in vitro nor for virulence in vivo. Veterinary Research. 44(1). 53–53. 37 indexed citations

Reschner, Anca, Yong‐Ho Shim, Philippe Dúbois, et al.. (2013). Evaluation of a New Biocompatible Poly(N-(Morpholino Ethyl Methacrylate)-Based Copolymer for the Delivery of Ruthenium Oligonucleotides, Targeting HPV16 E6 Oncogene. Journal of Biomedical Nanotechnology. 9(8). 1432–1440. 13 indexed citations

Reschner, Anca, Sébastien Bontems, Séverine Le Gac, et al.. (2012). Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53. Gene Therapy. 20(4). 435–443. 27 indexed citations

10.

Herfs, Michaël, Pascale Hubert, Meggy Suarez‐Carmona, et al.. (2010). Regulation of p63 Isoforms by Snail and Slug Transcription Factors in Human Squamous Cell Carcinoma. American Journal Of Pathology. 176(4). 1941–1949. 38 indexed citations

11.

Reschner, Anca, Helena Harlin, Brett A. Laven, et al.. (2009). Expression of immunomodulating genes in prostate cancer and benign prostatic tissue.. PubMed. 31(2). 74–82. 4 indexed citations

12.

Feder‐Mengus, Chantal, Sourabh Ghosh, Anca Reschner, Iván Martín, & Giulio C. Spagnoli. (2008). New dimensions in tumor immunology: what does 3D culture reveal?. Trends in Molecular Medicine. 14(8). 333–340. 110 indexed citations

13.

Feder‐Mengus, Chantal, Sourabh Ghosh, William P. Weber, et al.. (2007). Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes. British Journal of Cancer. 96(7). 1072–1082. 69 indexed citations

14.

Ghosh, Sourabh, Giulio C. Spagnoli, Iván Martín, et al.. (2005). Three‐dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study. Journal of Cellular Physiology. 204(2). 522–531. 266 indexed citations

15.

Holzen, Urs von, Michel Adamina, Martin Bolli, et al.. (2005). Selective responsiveness to common gamma chain cytokines in peripheral blood‐derived cytotoxic T lymphocytes induced by Melan‐A/MART‐1_27–35targeted active specific immunotherapy. International Journal of Cancer. 115(2). 248–255. 7 indexed citations

16.

Weber, William P., Chantal Feder‐Mengus, Alberto Chiarugi, et al.. (2005). Differential effects of the tryptophan metabolite3‐hydroxyanthranilic acid on the proliferation of human CD8⁺ T cells induced by TCR triggering or homeostatic cytokines. European Journal of Immunology. 36(2). 296–304. 72 indexed citations

17.

Ghosh, Sourabh, Rachel Rosenthal, Paul Zajac, et al.. (2005). Culture of Melanoma Cells in 3-Dimensional Architectures Results in Impaired Immunorecognition by Cytotoxic T Lymphocytes Specific for Melan-A/MART-1 Tumor-Associated Antigen. Annals of Surgery. 242(6). 851–858. 37 indexed citations

18.

Reschner, Anca, et al.. (2005). Synthetic bacterial lipopeptide analogs: structural requirements for adjuvanticity. Immunobiology. 210(2-4). 211–215. 11 indexed citations

19.

Adamina, Michel, Martin Bolli, Federica Albo, et al.. (2004). Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes. British Journal of Cancer. 90(1). 263–269. 17 indexed citations

20.

Reschner, Anca, Antonia Moretta, Régine Landmann, et al.. (2003). The ester‐bonded palmitoyl side chains of Pam₃CysSerLys₄ lipopeptide account for its powerful adjuvanticity to HLA class I‐restricted CD8⁺ T lymphocytes. European Journal of Immunology. 33(7). 2044–2052. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact